{"i": ["risedronate"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["risedronate"], "o": []}
{"i": ["placebo", "risedronate"], "o": []}
{"i": [], "o": []}
{"i": ["placebo", "risedronate"], "o": ["3 - year hip fracture incidence"]}
{"i": [], "o": []}
{"i": ["placebo", "risedronate"], "o": ["hip fracture"]}
{"i": ["Risedronate"], "o": []}
{"i": [], "o": []}
{"i": ["risedronate"], "o": []}
{"i": ["placebo", "risedronate"], "o": []}
{"i": [], "o": []}
{"i": ["placebo", "risedronate"], "o": ["3 - year hip fracture incidence"]}
{"i": [], "o": []}
{"i": ["placebo", "risedronate"], "o": ["hip fracture"]}
{"i": ["Risedronate"], "o": []}
{"i": ["Zoledronic acid", "Risedronate"], "o": []}
{"i": ["Risedronate Therapy", "risedronate"], "o": ["vertebral fractures"]}
{"i": ["risedronate"], "o": []}
{"i": [], "o": []}
{"i": ["risedronate", "placebo"], "o": ["Hip fracture incidence"]}
{"i": ["placebo - controlled"], "o": []}
{"i": [], "o": []}
{"i": ["risedronate", "placebo ."], "o": []}
{"i": ["1000 mg elemental calcium", "vitamin D"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["incidence of radiographically confirmed hip fractures ."]}
{"i": [], "o": ["vertebral fracture status"]}
{"i": ["risedronate", "placebo ."], "o": []}
{"i": [], "o": ["Kaplan - Meier survival ( time - to - first fracture )", "incidence of hip fracture"]}
{"i": ["placebo", "risedronate"], "o": ["hip fracture"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["BMD"]}
{"i": ["placebo", "risedronate"], "o": []}
{"i": ["placebo"], "o": []}
{"i": ["placebo"], "o": ["Hip fracture"]}
{"i": ["placebo", "risedronate"], "o": ["incidence of hip fracture"]}
{"i": ["risedronate", "placebo"], "o": ["risk of hip fracture"]}
{"i": [], "o": ["any adverse event", "serious adverse event , or who withdrew because of an adverse event"]}
{"i": [], "o": ["incidence of death"]}
{"i": ["bisphosphonate"], "o": []}
{"i": ["risedronate", "placebo"], "o": ["risk of hip fracture"]}
{"i": ["placebo"], "o": ["incidence of hip fracture"]}
{"i": [], "o": []}
{"i": ["placebo", "risedronate"], "o": ["hip fracture"]}
{"i": ["placebo"], "o": ["fracture incidence", "fracture risk"]}
{"i": ["bisphosphonate ( zoledronic acid"], "o": ["hip fracture"]}
{"i": ["placebo", "zoledronic acid"], "o": ["hip fracture incidence"]}
{"i": ["strontium ranelate", "alendronate"], "o": ["risk of hip fracture", "incidence of hip fracture in", "hip fractures"]}
{"i": [], "o": []}
{"i": ["drug treatment", "fall prevention advice"], "o": []}
{"i": ["bisphosphonate"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["hip fracture prevention"]}
{"i": ["risedronate"], "o": ["risk of hip fracture"]}
{"i": [], "o": []}
{"i": ["bone - directed therapy"], "o": []}
